siRNA / miRNA gene silencing Human UCC (urothelial cancer cell lines)

- Found 8759 results

Gene silencing through the use of small interfering RNA (siRNA) has become a primary tool for identifying disease-causing genes. There are several aspects for preparing and delivering effective siRNA to knockdown a target gene. The length of siRNA should be 21–23nt long with G/C content 30–50%. If a validated siRNA sequence for your target gene is not available, use siRNA generated against the entire target gene ORF. Always work with two or three different siRNA constructs to get reliable results. If you are not sure how much siRNA to use for a given experiment, start with a transfection concentration of 10-50 nM and use siRNA-specific transfection reagent to ensure efficient siRNA delivery in a wide range of cells.

RNA siRNA / miRNA gene silencing Mouse Neuro 2a c-Jun

Gene silencing through the use of small interfering RNA (siRNA) has become a primary tool for identifying disease-causing genes. There are several aspects for preparing and delivering effective siRNA to knockdown a target gene. The length of siRNA should be 21–23nt long with G/C content 30–50%. If a validated siRNA sequence for your target gene is not available, use siRNA generated against the entire target gene ORF. Always work with two or three different siRNA constructs to get reliable results. If you are not sure how much siRNA to use for a given experiment, start with a transfection concentration of 10-50 nM and use siRNA-specific transfection reagent to ensure efficient siRNA delivery in a wide range of cells.

RNA siRNA / miRNA gene silencing Mouse B16-F10 COX-2

RNA siRNA / miRNA gene silencing Human Jurkat MK2 (MAPK Kinase 2) Viral vectors

RNA siRNA / miRNA gene silencing Human U937 MK2 (MAPK Kinase 2) Viral vectors

RNA siRNA / miRNA gene silencing Human Primary Endometrial Stromal Cells hsa-miR-542-3p Lipid

RNA siRNA / miRNA gene silencing Human 501 Mel and SK Mel 28 FANCD2 Polymer / Lipid

Reporter gene assays enable high sensitivity measurement of gene expression and cell signaling through the addition of bioluminescent genes into target cells. One of the major challenges is to make a specific construct that has no responses other than those related to the signaling pathway of interest. This can be achieved by selecting highly specific reporter constructs containing only defined responsive elements and a minimal promoter linked to reporter enzymes such as luciferase

Cellular assays Reporter gene assay luciferase SW480 human colon cancer cell line

RNA siRNA / miRNA gene silencing Mouse BV2 LGAL3S3

RNA siRNA / miRNA gene silencing Rat PC12 chorein

RNA siRNA / miRNA gene silencing Rat PC12 SOD2

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms